{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:44:19Z","timestamp":1785199459177,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Acinetobacter baumannii<\/jats:italic> complex (ABC) has emerged as an important pathogen causing a variety of infections. Longitudinal multicenter surveillance data on ABC from different sources in Taiwan have not been published. Using data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) conducted biennially, we investigated the secular change in resistance of 1640 ABC from 2002 to 2010 (TSAR period III to VII) to different antimicrobial agents and identified factors associated with imipenem-resistant and extensively drug-resistant ABC (IRABC and XDRABC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Isolates were collected by TSAR from the same 26 hospitals located in all 4 regions of Taiwan. Minimum inhibitory concentrations (MIC) were determined by reference broth microdilution method. Isolates nonsusceptible to all tested aminoglycosides, fluoroquinolones, \u03b2-lactam, \u03b2-lactam\/\u03b2-lactam inhibitors, and carbapenems were defined as extensively drug-resistant (XDR). Multivariate logistic regression analysis was performed to assess the relationship between predictor variables among patients with resistant ABC and patients with non-resistant ABC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The prevalence of IRABC increased from 3.4% in 2002 to 58.7% in 2010 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001; odds ratio [OR], 2.138; 95% confidence interval [CI], 1.947 to 2.347) and that of XDRABC increased from 1.3% in 2002 to 41.0% in 2010 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001; OR, 1.970; 95% CI, 1.773-2.189). The rates of non-susceptibility to other antimicrobial agents remained high (&gt;55%) over the years with some fluctuations before and after TSAR V (2006) on some agents. Multivariate analysis revealed that recovery from elderly patients, origins other than blood, from ICU settings, or geographic regions are independent factors associated with IRABC and XDRABC. Although the prevalence of XDRABC increased in all four regions of Taiwan over the years, central Taiwan had higher prevalence of XDRABC starting in 2008. Susceptibility to polymyxin remained high (99.8%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This longitudinal multicenter surveillance program revealed significant increase and nationwide emergence of IRABC and XDRABC in Taiwan over the years. This study also identified factors associated with IRABC and XDRABC to help guide empirical therapy and at-risk groups requiring more intense interventional infection control measures with focused surveillance efforts.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-12-200","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T04:14:15Z","timestamp":1346127255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10\u2009years: Nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program"],"prefix":"10.1186","volume":"12","author":[{"given":"Shu-Chen","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Fen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Ru","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Ling Yang","family":"Lauderdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TSAR Hospitals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,28]]},"reference":[{"key":"1983_CR1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","volume":"21","author":"AY Peleg","year":"2008","unstructured":"Peleg AY, Seifert H, Paterson DL: Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008, 21: 538-582. 10.1128\/CMR.00058-07.","journal-title":"Clin Microbiol Rev"},{"key":"1983_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nrmicro1789","volume":"5","author":"L Dijkshoorn","year":"2007","unstructured":"Dijkshoorn L, Nemec A, Seifert H: An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007, 5: 939-951. 10.1038\/nrmicro1789.","journal-title":"Nat Rev Microbiol"},{"key":"1983_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijantimicag.2010.10.014","volume":"37","author":"IK Neonakis","year":"2011","unstructured":"Neonakis IK, Spandidos DA, Petinaki E: Confronting multidrug-resistant Acinetobacter baumannii: a review. Int J Antimicrob Agents. 2011, 37: 102-109. 10.1016\/j.ijantimicag.2010.10.014.","journal-title":"Int J Antimicrob Agents"},{"key":"1983_CR4","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1128\/AAC.01464-06","volume":"51","author":"F Perez","year":"2007","unstructured":"Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA: Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007, 51: 3471-3484. 10.1128\/AAC.01464-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"1983_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/jac\/dkl499","volume":"59","author":"KT Kwon","year":"2007","unstructured":"Kwon KT, Oh WS, Song JH, Chang HH, Jung SI, Kim SW, Ryu SY, Heo ST, Jung DS, Rhee JY, et al: Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother. 2007, 59: 525-530. 10.1093\/jac\/dkl499.","journal-title":"J Antimicrob Chemother"},{"key":"1983_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3201\/eid1301.060716","volume":"13","author":"RH Sunenshine","year":"2007","unstructured":"Sunenshine RH, Wright M-O, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, et al: Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis. 2007, 13: 97-103. 10.3201\/eid1301.060716.","journal-title":"Emerg Infect Dis"},{"key":"1983_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1445-5994.2006.01130.x","volume":"36","author":"AY Peleg","year":"2006","unstructured":"Peleg AY, Paterson DL: Multidrug-resistant Acinetobacter: a threat to the antibiotic era. Intern Med J. 2006, 36: 479-482. 10.1111\/j.1445-5994.2006.01130.x.","journal-title":"Intern Med J"},{"key":"1983_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.diagmicrobio.2007.09.006","volume":"60","author":"PJ Turner","year":"2008","unstructured":"Turner PJ: Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Diagn Microbiol Infect Dis. 2008, 60: 185-192. 10.1016\/j.diagmicrobio.2007.09.006.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1983_CR9","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/jac\/dkr239","volume":"66","author":"AC Gales","year":"2011","unstructured":"Gales AC, Jones RN, Sader HS: Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006\u201309). J Antimicrob Chemother. 2011, 66: 2070-2074. 10.1093\/jac\/dkr239.","journal-title":"J Antimicrob Chemother"},{"key":"1983_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijantimicag.2011.01.009","volume":"37","author":"S-S Jean","year":"2011","unstructured":"Jean S-S, Hsueh P-R: High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents. 2011, 37: 291-295. 10.1016\/j.ijantimicag.2011.01.009.","journal-title":"Int J Antimicrob Agents"},{"key":"1983_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.diagmicrobio.2003.10.005","volume":"48","author":"TL Lauderdale","year":"2004","unstructured":"Lauderdale TL, Clifford McDonald L, Shiau YR, Chen PC, Wang HY, Lai JF, Ho M: The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000. Diagn Microbiol Infect Dis. 2004, 48: 211-219. 10.1016\/j.diagmicrobio.2003.10.005.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"1983_CR12","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/jac\/dkn348","volume":"62","author":"AR White","year":"2008","unstructured":"White AR, Surveillance BWPoR: The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: a successful collaborative model. J Antimicrob Chemother. 2008, 62 (2): ii3-ii14. 10.1093\/jac\/dkn348.","journal-title":"J Antimicrob Chemother"},{"key":"1983_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jmii.2011.03.001","volume":"44","author":"SH Tseng","year":"2011","unstructured":"Tseng SH, Lee CM, Lin TY, Chang SC, Chang FY: Emergence and spread of multi-drug resistant organisms: think globally and act locally. J Microbiol Immunol Infect. 2011, 44: 157-165. 10.1016\/j.jmii.2011.03.001.","journal-title":"J Microbiol Immunol Infect"},{"key":"1983_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijantimicag.2008.08.026","volume":"33","author":"S-S Jean","year":"2009","unstructured":"Jean S-S, Hsueh P-R, Lee W-S, Chang H-T, Chou M-Y, Chen I-S, Wang J-H, Lin C-F, Shyr J-M, Ko W-C, et al: Nationwide surveillance of antimicrobial resistance among non-fermentative Gram-negative bacteria in Intensive Care Units in Taiwan: SMART programme data 2005. Int J Antimicrob Agents. 2009, 33: 266-271. 10.1016\/j.ijantimicag.2008.08.026.","journal-title":"Int J Antimicrob Agents"},{"key":"1983_CR15","first-page":"239","volume":"32","author":"M Ho","year":"1999","unstructured":"Ho M, McDonald LC, Lauderdale TL, Yeh LL, Chen PC, Shiau YR: Surveillance of antibiotic resistance in Taiwan, 1998. J Microbiol Immunol Infect. 1999, 32: 239-249.","journal-title":"J Microbiol Immunol Infect"},{"key":"1983_CR16","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1128\/JCM.06711-11","volume":"50","author":"FJ Chen","year":"2012","unstructured":"Chen FJ, Huang IW, Wang CH, Chen PC, Wang HY, Lai JF, Shiau YR, Lauderdale TL: mecA-positive Staphylococcus aureus with low-level oxacillin MIC in Taiwan. J Clin Microbiol. 2012, 50: 1679-1683. 10.1128\/JCM.06711-11.","journal-title":"J Clin Microbiol"},{"key":"1983_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jmii.2011.09.028","volume":"45","author":"H Wu","year":"2012","unstructured":"Wu H, Wang JT, Shiau YR, Wang HY, Lauderdale TL, Chang SC: A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan. J Microbiol Immunol Infect. 2012, 45: 120-126. 10.1016\/j.jmii.2011.09.028.","journal-title":"J Microbiol Immunol Infect"},{"key":"1983_CR18","volume-title":"Manual of Clinical Microbiology","author":"PC Schreckenberger","year":"1999","unstructured":"Schreckenberger PC, von Graevenitz A: Acinetobacter, Achromobacter, Alcaligenes, Moraxella, and other nonfermentative Gram-negative rods. p. 539\u2013560. Manual of Clinical Microbiology. Edited by: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. 1999, American Society for Microbiology, Washington, D.C., 7","edition":"7"},{"key":"1983_CR19","volume-title":"Performance Standards for Antimicrobial Susceptibility testing; Twenty-First Information Supplement","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2011","unstructured":"Clinical and Laboratory Standards Institute (CLSI): Performance Standards for Antimicrobial Susceptibility testing; Twenty-First Information Supplement. 2011, CLSI document M100-S21, CLSI, Wayne, PA"},{"key":"1983_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al: Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012, 18: 268-281. 10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"key":"1983_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1128\/AAC.00850-10","volume":"55","author":"TY Tan","year":"2011","unstructured":"Tan TY, Lim TP, Lee WH, Sasikala S, Hsu LY, Kwa AL: In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods. Antimicrob Agents Chemother. 2011, 55: 436-438. 10.1128\/AAC.00850-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"1983_CR22","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1093\/clinids\/24.Supplement_1.S157","volume":"24","author":"JM Stelling","year":"1997","unstructured":"Stelling JM, O'Brien TF: Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis. 1997, 24 (Suppl 1): S157-168.","journal-title":"Clin Infect Dis"},{"key":"1983_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jama.2009.1144","volume":"302","author":"N Scarmeas","year":"2009","unstructured":"Scarmeas N, Luchsinger JA, Schupf N, Brickman AM, Cosentino S, Tang MX, Stern Y: Physical activity, diet, and risk of Alzheimer disease. JAMA. 2009, 302: 627-637. 10.1001\/jama.2009.1144.","journal-title":"JAMA"},{"key":"1983_CR24","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/jac\/dkm310","volume":"60","author":"RR Reinert","year":"2007","unstructured":"Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ: Antimicrobial susceptibility among organisms from the Asia\/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother. 2007, 60: 1018-1029. 10.1093\/jac\/dkm310.","journal-title":"J Antimicrob Chemother"},{"key":"1983_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jhin.2006.04.015","volume":"64","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Kopterides P: Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect. 2006, 64: 7-15. 10.1016\/j.jhin.2006.04.015.","journal-title":"J Hosp Infect"},{"key":"1983_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jmii.2011.01.008","volume":"44","author":"MF Lin","year":"2011","unstructured":"Lin MF, Kuo HY, Yeh HW, Yang CM, Sung CH, Tu CC, Huang ML, Liou ML: Emergence and dissemination of bla(OXA-23)-carrying imipenem-resistant Acinetobacter sp. in a regional hospital in Taiwan. J Microbiol Immunol Infect. 2011, 44: 39-44. 10.1016\/j.jmii.2011.01.008.","journal-title":"J Microbiol Immunol Infect"},{"key":"1983_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/jac\/dkn553","volume":"63","author":"PL Lu","year":"2009","unstructured":"Lu PL, Doumith M, Livermore DM, Chen TP, Woodford N: Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J Antimicrob Chemother. 2009, 63: 641-647. 10.1093\/jac\/dkn553.","journal-title":"J Antimicrob Chemother"},{"key":"1983_CR28","doi-asserted-by":"publisher","first-page":"e37788","DOI":"10.1371\/journal.pone.0037788","volume":"7","author":"CH Su","year":"2012","unstructured":"Su CH, Wang JT, Hsiung CA, Chien LJ, Chi CL, Yu HT, Chang FY, Chang SC: Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One. 2012, 7: e37788-10.1371\/journal.pone.0037788.","journal-title":"PLoS One"},{"key":"1983_CR29","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03695.x","volume":"18","author":"Y Smani","year":"2012","unstructured":"Smani Y, Lopez-Rojas R, Dominguez-Herrera J, Docobo-Perez F, Marti S, Vila J, Pachon J: In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii. Clin Microbiol Infect. 2012, 18: E1-E4. 10.1111\/j.1469-0691.2011.03695.x.","journal-title":"Clin Microbiol Infect"},{"key":"1983_CR30","volume-title":"J Clin Pharmacol","author":"J Cao","year":"2012","unstructured":"Cao J, Song W, Gu B, Mei YN, Tang JP, Meng L, Yang CQ, Wang H, Zhou H: Correlation between carbapenem consumption and antimicrobial resistance rates of Acinetobacter baumannii in a university-affiliated hospital in China. J Clin Pharmacol. 2012, Feb 02 [Epub ahead of print]"},{"key":"1983_CR31","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/jac\/dkm305","volume":"60","author":"KS Ko","year":"2007","unstructured":"Ko KS, Suh JY, Kwon KT, Jung S-I, Park K-H, Kang CI, Chung DR, Peck KR, Song J-H: High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother. 2007, 60: 1163-1167. 10.1093\/jac\/dkm305.","journal-title":"J Antimicrob Chemother"},{"key":"1983_CR32","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jinf.2010.03.024","volume":"60","author":"DJ Farrell","year":"2010","unstructured":"Farrell DJ, Turnidge JD, Bell J, Sader HS, Jones RN: The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008). J Infect. 2010, 60: 440-451. 10.1016\/j.jinf.2010.03.024.","journal-title":"J Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-200\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:50:21Z","timestamp":1630525821000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1983"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-200","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,28]]},"assertion":[{"value":"11 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"200"}}